Early Aubagio ‘preferable for preventing disease progression’
Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more - http://www.ms-uk.org/MSnews
Early Aubagio ‘preferable for preventing disease progression
Early Aubagio ‘preferable for preventing disease progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2505 Views
-
Last post by NHE
-
- 0 Replies
- 1202 Views
-
Last post by frodo
-
- 0 Replies
- 1119 Views
-
Last post by NHE
-
- 0 Replies
- 1307 Views
-
Last post by frodo
-
- 0 Replies
- 1441 Views
-
Last post by NHE
-
- 0 Replies
- 1180 Views
-
Last post by frodo
-
- 0 Replies
- 1515 Views
-
Last post by NHE
-
- 0 Replies
- 1792 Views
-
Last post by DIM
-
- 0 Replies
- 1430 Views
-
Last post by NHE